Preoperative Bintrafusp Alfa in Operable Urothelial Carcinoma of the Bladder
NCT04878250
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
49
Enrollment
OTHER
Sponsor class
Conditions
Transitional Cell Carcinoma
Bladder Cancer
Interventions
DRUG:
Bintrafusp alfa
Sponsor
Queen Mary University of London